Kinase inhibitors and method of treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9907800
SERIAL NO

14823057

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY HEALTH NETWORK190 ELIZABETH STREET R FRASER ELLIOTT BUILDING - ROOM 1S-417 TORONTO M5G 2C4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Edwards, Louise G Mississauga, CA 15 192
Feher, Miklos New York, US 24 256
Forrest, Bryan T Burlington, CA 17 207
Laufer, Radoslaw Oakville, CA 39 489
Li, Sze-Wan Toronto, CA 36 262
Liu, Yong Oakville, CA 1235 24302
Patel, Narendra Kumar B Brampton, CA 26 240
Pauls, Heinz W Oakville, CA 58 617
Sampson, Peter Brent Oakville, CA 29 216

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00